Switching children previously exposed to nevirapine to nevirapine-based treatment after initial suppression with a protease-inhibitor-based regimen: long-term follow-up of a randomised, open-label trial
about
Treatment of young children with HIV infection: using evidence to inform policymakersGetting to 90-90-90 in paediatric HIV: What is needed?Concordance between allele-specific PCR and ultra-deep pyrosequencing for the detection of HIV-1 non-nucleoside reverse transcriptase inhibitor resistance mutations.Induction with lopinavir-based treatment followed by switch to nevirapine-based regimen versus non-nucleoside reverse transcriptase inhibitors-based treatment for first line antiretroviral therapy in HIV infected children three years and older.Plasma lopinavir concentrations predict virological failure in a cohort of South African children initiating a protease-inhibitor-based regimenSex differences in responses to antiretroviral treatment in South African HIV-infected children on ritonavir-boosted lopinavir- and nevirapine-based treatment.Case report: Severe central nervous system manifestations associated with aberrant efavirenz metabolism in children: the role of CYP2B6 genetic variation.Cost-effectiveness of first-line antiretroviral therapy for HIV-infected African children less than 3 years of age.Young age at start of antiretroviral therapy and negative HIV antibody results in HIV-infected children when suppressed.Drug resistance among newly diagnosed HIV-infected children in the era of more efficacious antiretroviral prophylaxis.Efavirenz is associated with higher bone mass in South African children with HIV.Efavirenz-Based Antiretroviral Therapy Among Nevirapine-Exposed HIV-Infected Children in South Africa: A Randomized Clinical Trial90-90-90--Charting a steady course to end the paediatric HIV epidemic.Adherence and viral suppression among infants and young children initiating protease inhibitor-based antiretroviral therapy.Initiation of antiretroviral therapy before 6 months of age is associated with faster growth recovery in South African children perinatally infected with human immunodeficiency virusDecreased Vigorous Physical Activity in School-Aged Children with Human Immunodeficiency Virus in Johannesburg, South Africa.Development of antiretroviral resistance in children with HIV in low- and middle-income countriesPoor early virologic performance and durability of abacavir-based first-line regimens for HIV-infected children.Human Immunodeficiency Virus-1 Sequence Changes and Drug Resistance Mutation Among Virologic Failures of Lopinavir/Ritonavir Monotherapy: AIDS Clinical Trials Group Protocol A5230.Immediate antiretroviral therapy in young HIV-infected children: benefits and risks.Effect of Lopinavir and Nevirapine Concentrations on Viral Outcomes in Protease Inhibitor-experienced HIV-infected ChildrenExtent of disclosure: what perinatally HIV-infected children have been told about their own HIV status.Patterns of Growth, Body Composition, and Lipid Profiles in a South African Cohort of Human Immunodeficiency Virus-Infected and Uninfected Children: A Cross-Sectional Study.Moving forward with treatment options for HIV-infected children.Switching to Efavirenz Versus Remaining on Ritonavir-boosted Lopinavir in Human Immunodeficiency Virus-infected Children Exposed to Nevirapine: Long-term Outcomes of a Randomized Trial.Early age at start of antiretroviral therapy associated with better virologic control after initial suppression in HIV-infected infants.Paediatric European Network for Treatment of AIDS (PENTA) guidelines for treatment of paediatric HIV-1 infection 2015: optimizing health in preparation for adult life.HIV drug resistance in African infants and young children newly diagnosed with HIV: a multicounty analysis.Defining Study Outcomes That Better Reflect Individual Response to Treatment.
P2860
Q26864053-491D1A7A-D52E-4FBE-9E17-FE5E4316C473Q30385352-21B89CF2-79FB-4607-81B1-AFF0850D6A94Q34112568-EB64E8DB-4822-4C6B-99D5-24D47808C3E8Q34215346-40D5D38D-915B-4A67-8DB7-AA60BD6C7ED9Q34498914-F6BE323B-57F5-49C2-A043-BDA8FC034B5BQ35093189-E24BBAA6-D9F7-4F0A-96E3-5EC8877B612FQ35910664-B64AF250-9E50-4576-8DF2-4B38BBB917EEQ35955127-D9407838-CB16-4E3B-BCA2-36568A78FC8CQ35962423-282AA054-39A1-40C7-BFA4-B9B3C0C83739Q35965344-EE114639-0E37-45E8-8BB1-11CE2CD6E6E5Q36079798-8ECC0F5C-1EC8-4A4F-9A01-E46C4E5005C3Q36306986-395CAE82-9C85-4FE6-987D-D70B1EDCBE8AQ36349696-9FB3D314-5BC0-4F58-A487-D293E074904CQ36759507-4899E6D4-C0EF-468D-B67F-01D43598DB21Q36807963-0E02D0F9-36EA-4793-944B-3D39FDFB76E3Q36839977-EAAE6C22-7090-4D87-B2A4-E5DACA3C781DQ36852631-6FAA6BD3-6499-4555-AB02-82118641F26DQ37029110-A73CF5CD-0640-4FD1-86AE-3108755ED0CFQ37305622-923D0590-898B-4C9B-B2C0-6511BAD7ABFAQ37403284-17D4CB9F-5B71-4DDD-BF1B-0AE82B45A738Q37513856-33B5AF92-0408-472F-A6F3-6EA58668F117Q37653305-E41E26DD-3877-4AA0-A475-08F184D26FF3Q38798094-E82592E6-86F1-426B-B50A-09DB48092BD6Q40063042-15013225-7933-4308-8DA6-FA449B1E0392Q40238381-9E713CD0-9D51-492F-BB19-BCBFE5D88CA9Q40458484-3FF3372D-E9E5-4164-984F-46DBE473F435Q41505058-2FA188EF-B515-44EC-983F-C1B067D193D3Q41919022-026DA2C3-4964-4687-8BC3-4C9A32338BA8Q47571203-4ADAF2B4-0352-4507-8A6B-EAA9149417B3
P2860
Switching children previously exposed to nevirapine to nevirapine-based treatment after initial suppression with a protease-inhibitor-based regimen: long-term follow-up of a randomised, open-label trial
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Switching children previously ...... a randomised, open-label trial
@ast
Switching children previously ...... a randomised, open-label trial
@en
type
label
Switching children previously ...... a randomised, open-label trial
@ast
Switching children previously ...... a randomised, open-label trial
@en
prefLabel
Switching children previously ...... a randomised, open-label trial
@ast
Switching children previously ...... a randomised, open-label trial
@en
P2093
P2860
P50
P1476
Switching children previously ...... a randomised, open-label trial
@en
P2093
Chih-Chi Hu
Deborah Persaud
Gayle Sherman
Gillian Hunt
Leigh Martens
Tammy Meyers
Wei-Yann Tsai
P2860
P304
P356
10.1016/S1473-3099(12)70051-8
P577
2012-03-16T00:00:00Z